Literature DB >> 1312626

Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.

N M Sawtell1, R L Thompson.   

Abstract

Defined herpes simplex virus type 1 (HSV-1) mutants KOS/1 and KOS/62 (positive and negative, respectively, for latency-associated transcripts [LATs]) express the Escherichia coli beta-galactosidase (beta-Gal) gene during latency. These mutants were employed to assess the functions of the latency-associated transcription unit on establishment and maintenance of and reactivation from the latent state. It was found that in the trigeminal ganglia, the frequencies of hyperthermia-induced reactivation of KOS/62 and an additional LATs- mutant (KOS/29) were reduced by at least 80%. Quantification of latently infected neurons expressing the beta-Gal gene revealed that the LATs- mutant KOS/62 established approximately 80% fewer latent infections in the trigeminal ganglia than did KOS/1 (LATs+). This reduction in establishment which is evident in the trigeminal ganglia could account for the reduced frequency of reactivation from this site. In striking contrast, both LATs- mutants reactivated with wild-type frequencies from lumbosacral ganglia. Quantification of beta-Gal-positive neurons at this site revealed that KOS/62 established as many as or more latent infections than the LATs+ virus, KOS/1. Colocalization of HSV antigen and beta-Gal suggested that the decreased establishment by LATs- mutants in trigeminal ganglia was the result of inefficient viral shutoff. Thus, one function of the HSV-1 LATs transcription unit is to promote the establishment of latency in trigeminal but not lumbosacral ganglia. Such a function may be relevant to understanding the distinct clinical recurrent disease patterns of HSV-1 and HSV-2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312626      PMCID: PMC289008     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity.

Authors:  B C Herold; D WuDunn; N Soltys; P G Spear
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Cell lines derived from dorsal root ganglion neurons are nonpermissive for HSV and express only the latency-associated transcript following infection.

Authors:  S C Wheatley; L M Kemp; J N Wood; D S Latchman
Journal:  Exp Cell Res       Date:  1990-10       Impact factor: 3.905

3.  Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants.

Authors:  J P Katz; E T Bodin; D M Coen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript.

Authors:  J C Zwaagstra; H Ghiasi; S M Slanina; A B Nesburn; S C Wheatley; K Lillycrop; J Wood; D S Latchman; K Patel; S L Wechsler
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia.

Authors:  W J Mitchell; S L Deshmane; A Dolan; D J McGeoch; N W Fraser
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  A herpes simplex virus type 1 variant, deleted in the promoter region of the latency-associated transcripts, does not produce any detectable minor RNA species during latency in the mouse trigeminal ganglion.

Authors:  W J Mitchell; I Steiner; S M Brown; A R MacLean; J H Subak-Sharpe; N W Fraser
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

7.  Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1.

Authors:  W J Mitchell; R P Lirette; N W Fraser
Journal:  J Gen Virol       Date:  1990-01       Impact factor: 3.891

8.  Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1.

Authors:  A H Batchelor; P O'Hare
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection.

Authors:  T M Block; J G Spivack; I Steiner; S Deshmane; M T McIntosh; R P Lirette; N W Fraser
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

10.  Relationship between polyadenylated and nonpolyadenylated herpes simplex virus type 1 latency-associated transcripts.

Authors:  G B Devi-Rao; S A Goodart; L M Hecht; R Rochford; M K Rice; E K Wagner
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more
  134 in total

1.  Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region.

Authors:  H Berthomme; J Thomas; P Texier; A Epstein; L T Feldman
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.

Authors:  Maryam Ahmed; Martin Lock; Cathie G Miller; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.

Authors:  X J Da Costa; C A Jones; D M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells.

Authors:  Edward A Burton; Chang-Sook Hong; Joseph C Glorioso
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 5.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

6.  VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.

Authors:  Nancy M Sawtell; Steven J Triezenberg; Richard L Thompson
Journal:  J Neurovirol       Date:  2011-12-06       Impact factor: 2.643

Review 7.  Herpes simplex virus latency-associated transcript gene function.

Authors:  Jennifer R Kent; Wen Kang; Cathie G Miller; Nigel W Fraser
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

8.  Two open reading frames (ORF1 and ORF2) within the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1 are not essential for reactivation from latency.

Authors:  M U Fareed; J G Spivack
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.

Authors:  G C Perng; E C Dunkel; P A Geary; S M Slanina; H Ghiasi; R Kaiwar; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.

Authors:  L I Strelow; D A Leib
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.